Skip to content Skip to navigation

Pain Management

Kratom research sorely needed for clinical, policy decisions

October 13, 2016  |  Julie Miller, Editor in Chief
The Drug Enforcement Administration (DEA) has slowed its move to place kratom on its most restrictive scheduling, as members of the research community argue against blocking studies of possible analgesic benefits.

Younger adult overdoses on the rise in Virginia

September 21, 2016  |  Tom Valentino, Senior Editor
Adults ages 25 to 44 accounted for more than half of all drug overdose-related deaths in Virginia from 2007 to 2014, according to research published this week.

Conference report: Presenter shows unbridled enthusiasm for methadone, buprenorphine

September 10, 2016  |  Gary A. Enos, Editor
A physician presenting at the Cape Cod Symposium on Addictive Disorders endorsed much wider access to both methadone and buprenorphine treatment for opioid dependence.

Some doctors pursuing genetic clues to medication response or misuse

September 1, 2016  |  Gary A. Enos, Editor
Predictive testing to evaluate the potential risks and benefits of opioids and other medications appears to have wide applicability in many sectors of healthcare.

FDA mandates warnings, education on use of opioids with benzodiazepines

September 1, 2016  |  Gary A. Enos, Editor
Based partly on findings of increases in overdoses from concurrent prescribing of opioids and benzodiazepines, the Food and Drug Administration (FDA) is requiring boxed warnings and patient guides for nearly 400 individual drugs.

Acupuncture helps keep patients in treatment

August 20, 2016  |  Tom Valentino, Senior Editor
The National Acupuncture Detoxification Association’s 5-point ear acupuncture protocol is not a standalone replacement for other forms of addiction treatment, but when used in conjunction with those programs, it can increase their effectiveness.

Significant prevalence of gabapentin misuse seen in pain patients

August 5, 2016  |  Gary A. Enos, Editor
Data presented this week at a national scientific meeting indicate that a significant number of prescription opioid users are misusing the anti-seizure medication gabapentin.

Data on concurrent use of heroin, benzodiazepines alarm researchers

August 2, 2016  |  Gary A. Enos, Editor
A Quest Diagnostics trends report has found that among patients who used heroin, nearly one in three also were using benzodiazepines, in a highly dangerous combination.

Testing company launches trial in screening for genetic variables in drug response

July 22, 2016  |  Gary A. Enos, Editor
InSource Diagnostics is recruiting patients for a study employing urine testing to help determine which patients have a genetic mutation affecting response to drugs such as opioids.

Research finds gap in Maine pharmacists' use of PDMP

July 5, 2016  |  Gary A. Enos, Editor
A Husson University study of 2014 trends found that only 56% of a group of pharmacists reported accessing the state's prescription drug monitoring program (PDMP) database.

Lakeview Health adds pain specialist to medical team

June 29, 2016  |  Gary A. Enos, Editor
Adrian Blotner, MD, board-certified in psychiatry and pain medicine, will serve as campus psychiatrist for Lakeview Health's gender-separate programs.

Report: States missing the mark on protecting public from opioid overdose

June 28, 2016  |  Gary A. Enos, Editor
The National Safety Council states in a new report that only four states meet five of six indicators of progress in combating the opioid overdose crisis, with no states meeting all six criteria.


Subscribe to Pain Management